Aclaris Therapeutis (ACRS) PT Lowered to $34 at JMP Securities
Tweet
Share
E-mailGet Alerts ACRS Hot Sheet
Price: $6.17 +3.70%
Rating Summary:
15 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 0
Rating Summary:
15 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 0
Join SI Premium – FREE
JMP Securities analyst Donald Ellis lowered the price target on Aclaris Therapeutis (NASDAQ: ACRS) to $34.00 (from $47.00) while maintaining a Market Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Downgrades Xior Student Housing NV (XIOR:BB) to Hold
- Azzas 2154 SA (AZZA3:BZ) PT Lowered to R$30 at Jefferies
- Prudential Plc (2378:HK) PT Lowered to HK$149 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
